These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34562889)

  • 1. Biodegradable Metal Organic Frameworks for Multimodal Imaging and Targeting Theranostics.
    Lai X; Jiang H; Wang X
    Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
    Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-shell inorganic NP@MOF nanostructures for targeted drug delivery and multimodal imaging-guided combination tumor treatment.
    Khan S; Falahati M; Cho WC; Vahdani Y; Siddique R; Sharifi M; Jaragh-Alhadad LA; Haghighat S; Zhang X; Ten Hagen TLM; Bai Q
    Adv Colloid Interface Sci; 2023 Nov; 321():103007. PubMed ID: 37812992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
    Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
    Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal-Organic Frameworks for Biomedical Applications.
    Yang J; Yang YW
    Small; 2020 Mar; 16(10):e1906846. PubMed ID: 32026590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal-Organic Framework (MOF)-Based Drug Delivery.
    Cao J; Li X; Tian H
    Curr Med Chem; 2020; 27(35):5949-5969. PubMed ID: 31215374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of nanoscale metal-organic frameworks as imaging agents in biology and medicine.
    Demir Duman F; Forgan RS
    J Mater Chem B; 2021 Apr; 9(16):3423-3449. PubMed ID: 33909734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel formulations of metal-organic frameworks for controlled drug delivery.
    Rao C; Liao D; Pan Y; Zhong Y; Zhang W; Ouyang Q; Nezamzadeh-Ejhieh A; Liu J
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1183-1202. PubMed ID: 35426756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
    Mehata AK; Vikas ; Viswanadh MK; Muthu MS
    Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in porous MOFs and their hybrids for photothermal cancer therapy.
    Su J; Jing P; Jiang K; Du J
    Dalton Trans; 2022 Jun; 51(23):8938-8944. PubMed ID: 35642650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
    Wu MX; Yang YW
    Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and future prospects of nanoscale metal-organic frameworks in bioimaging.
    Nazari M; Saljooghi AS; Ramezani M; Alibolandi M; Mirzaei M
    J Mater Chem B; 2022 Nov; 10(43):8824-8851. PubMed ID: 36278809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticular Chemistry for Highly Porous Metal-Organic Frameworks: The Chemistry and Applications.
    Chen Z; Kirlikovali KO; Li P; Farha OK
    Acc Chem Res; 2022 Feb; 55(4):579-591. PubMed ID: 35112832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyrin NanoMetal-Organic Frameworks as Cancer Theranostic Agents.
    Figueira F; Tomé JPC; Paz FAA
    Molecules; 2022 May; 27(10):. PubMed ID: 35630585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal organic frameworks as advanced functional materials for aptasensor design.
    Khoshbin Z; Davoodian N; Taghdisi SM; Abnous K
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Aug; 276():121251. PubMed ID: 35429856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A γ-cyclodextrin-based metal-organic framework (γ-CD-MOF): a review of recent advances for drug delivery application.
    Hamedi A; Anceschi A; Patrucco A; Hasanzadeh M
    J Drug Target; 2022 Apr; 30(4):381-393. PubMed ID: 34847807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale MOFs: From synthesis to drug delivery and theranostics applications.
    Ding M; Liu W; Gref R
    Adv Drug Deliv Rev; 2022 Nov; 190():114496. PubMed ID: 35970275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-organic framework-based adsorbents for blood purification: progress, challenges, and prospects.
    Wang J; Cheng C; Sun S; Zhao W; Zhao C
    J Mater Chem B; 2024 Apr; 12(15):3594-3613. PubMed ID: 38506127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.